Summary
Axillary ultrasound (after neoadjuvant chemo-therapy can help to restage axillary nodal basins for patients with clinical node-positive (cN1) breast cancer, sparing many from the morbidity associated with axillary lymph node dissection. This article reports on the results of a secondary end point of the American College of Surgeons Oncology Group (ACOSOG) Z1071 trial.
- breast cancer
- radiology clinical trials
- ultrasonography
- adjuvant/neoadjuvant therapy
- © 2015 MD Conference Express®